The insider cluster is a bullish signal of confidence, but the concurrent dilutive offering is a material headwind. Watch for the stock's reaction to the offering close and any upcoming clinical data from the Phase 2 CRDF-004 trial. The mixed signals suggest limited near-term upside until the dilution is absorbed.
Price Chart
Executive Summary
Two insiders (CEO and a Director) purchased a total of ~$1.05M in CRDF shares at $1.455/share on July 14, two days before the company priced a dilutive ~$9.1M registered direct offering at $1.05/unit. The insider purchases represent 1.75% of market cap and were executed at a 38.6% premium to the offering price, signaling confidence despite the dilutive capital raise.
Key Financial Metrics
Key Facts
- CEO Mani Mohindru bought 34,364 shares ($50K) and Director Gary W. Pace bought 687,285 shares ($1M) on July 14 at $1.455/share.
- Total open-market purchases: $1.05M, or ~1.75% of CRDF's $60M market cap.
- The purchases occurred two days before a ~$9.1M registered direct offering at $1.05/unit (20% discount), with insiders paying a 38.6% premium.
- The offering dilutes existing shareholders by ~16.7%, offsetting the positive insider signal.
Financial Impact
Insider purchases of $1.05M (1.75% of market cap) alongside a ~$9.1M dilutive offering (16.7% dilution).
Risk Factors
- Dilution from the ~$9.1M offering will pressure the stock price.
- Clinical-stage biotech with no approved products; cash burn and trial failure risk remain high.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CRDF-1784278984440 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 4w ago | Institutional Cluster | $1.33 $1.17 | ▲ +12.03% | ▲ +10.84% | $0.7990 (+39.92%) |
Sep 14, 2026 6w ago | 8-K | $1.31 $1.37 | ▲ +4.58% | ▲ +4.47% | $0.7990 (−39.01%) |
Aug 11, 2026 10w ago | Press Release | $0.9900 $0.8979 | ▲ +9.30% | ▲ +8.86% | $0.7990 (+19.29%) |
Jul 16, 2026 14w ago | Insider Cluster | $0.8800 $0.8381 | ▼ −4.76% | ▼ −4.07% | $0.7990 (−9.20%) |
Jul 16, 2026 14w ago | 8-K | $0.8745 $0.8381 | ▲ +4.16% | ▲ +2.49% | $0.7990 (+8.63%) |
Jul 16, 2026 14w ago | 424B5 | $0.8745 $0.8381 | ▲ +4.16% | ▲ +2.49% | $0.7990 (+8.63%) |
Jun 22, 2026 18w ago | Insider Cluster | $1.30 $1.25 | ▼ −3.85% | ▼ −1.78% | $0.7990 (−38.54%) |
Jun 11, 2026 19w ago | Institutional Cluster | $1.59 $1.18 | ▲ +25.79% | ▲ +26.22% | $0.7990 (+49.75%) |
Jun 3, 2026 20w ago | 8-K | $1.40 $1.48 | ▲ +5.71% | ▲ +9.53% | $0.7990 (−42.93%) |
Jun 2, 2026 20w ago | Press Release | $1.51 $1.53 | ▲ +1.32% | ▲ +4.29% | $0.7990 (−47.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers